Pear Therapeutics vs PHIL
Pear Therapeutics vs PHIL, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Pear Therapeutics is on 49/100 and PHIL on 64/100.
Where each one leads
Pear Therapeutics
- domain rating: 54/100 against 44/100
- funding raised: $409M against $103M
PHIL
- our overall score: 64/100 against 49/100
- agent readiness: 41/100 against 21/100
At a glance
| Measure | Pear Therapeutics | PHIL |
|---|---|---|
| What it is | Pioneered prescription digital therapeutics for serious diseases, integrating software with pharmaceuticals. | Enabling pharmaceutical companies to deliver medications directly to patients at scale. |
| Category | HealthTech, MedTech, Biotech, Digital Therapeutics | HealthTech, Pharmaceuticals, Logistics, Fintech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Platform |
| Founded | 2013 | 2015 |
| Headquarters | Boston, United States | Scottsdale, USA |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Pear Therapeutics | PHIL |
|---|---|---|
| Employees | Not published | 279 |
| Total funding | $409M | $103M |
| Latest round | Post-IPO Equity | Growth Debt |
| Valuation | $1.6B | $1.1B |
| LinkedIn followers | Not published | 30,316 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Pear Therapeutics | PHIL |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 49/100 | 64/100 |
| Traction | 40/100 | Not published |
| Team | 70/100 | 100/100 |
| Search visibility | 11/100 | 81/100 |
| Quality | 58/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (41/100) |
| Domain ratingLink authority, 0-100 | 54/100 | 44/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Pear Therapeutics | PHIL |
|---|---|---|
| Hosting | Google Cloud | Netlify |
| CDN | Not detected | Netlify |
| Analytics | Not detected | Google Tag Manager |
| Support stack | Not detected | HubSpot |
Pear Therapeutics vs PHIL: common questions
Which is better, Pear Therapeutics or PHIL?
On our 0-100 score PHIL rates higher (64/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Pear Therapeutics and PHIL compare on the numbers?
Pear Therapeutics leads on domain rating (54/100 against 44/100), funding raised ($409M against $103M). PHIL leads on our overall score (64/100 against 49/100), agent readiness (41/100 against 21/100).
Read the full Pear Therapeutics review and pricing or the PHIL review and pricing. You can also browse other Pear Therapeutics alternatives we track.